SI2238458T1 - Metoda za napovedovanje odzivnosti na farmacevtsko zdravljenje debelosti - Google Patents

Metoda za napovedovanje odzivnosti na farmacevtsko zdravljenje debelosti

Info

Publication number
SI2238458T1
SI2238458T1 SI200830495T SI200830495T SI2238458T1 SI 2238458 T1 SI2238458 T1 SI 2238458T1 SI 200830495 T SI200830495 T SI 200830495T SI 200830495 T SI200830495 T SI 200830495T SI 2238458 T1 SI2238458 T1 SI 2238458T1
Authority
SI
Slovenia
Prior art keywords
obesity
pharmaceutical agent
predicting responsiveness
pharmaceutical therapy
biomarker
Prior art date
Application number
SI200830495T
Other languages
English (en)
Inventor
Jennifer K Leohr
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40386209&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2238458(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SI2238458T1 publication Critical patent/SI2238458T1/sl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI200830495T 2007-12-19 2008-12-18 Metoda za napovedovanje odzivnosti na farmacevtsko zdravljenje debelosti SI2238458T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1488107P 2007-12-19 2007-12-19
PCT/US2008/087367 WO2009085917A1 (en) 2007-12-19 2008-12-18 Method for predicting responsiveness to a pharmaceutical therapy for obesity
EP08867898A EP2238458B1 (en) 2007-12-19 2008-12-18 Method for predicting responsiveness to a pharmaceutical therapy for obesity

Publications (1)

Publication Number Publication Date
SI2238458T1 true SI2238458T1 (sl) 2012-02-29

Family

ID=40386209

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200830495T SI2238458T1 (sl) 2007-12-19 2008-12-18 Metoda za napovedovanje odzivnosti na farmacevtsko zdravljenje debelosti

Country Status (17)

Country Link
US (2) US8084261B2 (sl)
EP (2) EP2238458B1 (sl)
JP (1) JP5242701B2 (sl)
KR (2) KR101240875B1 (sl)
AT (1) ATE530916T1 (sl)
AU (2) AU2008343177B2 (sl)
BR (2) BRPI0821051B1 (sl)
CA (2) CA2710248A1 (sl)
CY (1) CY1112352T1 (sl)
DK (1) DK2238458T3 (sl)
ES (1) ES2373625T3 (sl)
HR (1) HRP20110840T1 (sl)
MX (1) MX2010006890A (sl)
PL (1) PL2238458T3 (sl)
PT (1) PT2238458E (sl)
SI (1) SI2238458T1 (sl)
WO (2) WO2009085927A1 (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2765617A1 (en) * 2009-07-22 2011-01-27 Eli Lilly And Company Method for predicting weight gain associated with a pharmaceutical therapy
US20160131603A1 (en) * 2013-06-18 2016-05-12 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Methods of predicting of chemical properties from spectroscopic data
WO2016065463A1 (en) * 2014-10-28 2016-05-06 2352409 Ontario Inc. Methods for providing personalized diet and activity recommendations that adapt to the metabolism of each dieter individually using frequent measurements of activity and triglyceride levels
KR102397234B1 (ko) 2020-09-17 2022-05-12 가천대학교 산학협력산 약물 순응도 평가 방법 및 시스템

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003450A1 (en) * 1991-07-30 1993-02-18 North Carolina State University Method and apparatus for measuring blood lipoprotein levels by nmr spectroscopy
FR2767135B1 (fr) * 1997-08-06 2002-07-12 Genset Sa Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
AU2054000A (en) * 1999-02-26 2000-09-14 Lipomed, Inc. Methods, systems, and computer program products for analyzing and presenting risk assessment results based on nmr lipoprotein analysis of blood
WO2003012416A1 (en) * 2001-08-01 2003-02-13 Liposcience, Inc. Method of determining presence and concentration of lipoprotein x in blood plasma and serum
CA2477614A1 (en) * 2002-03-05 2003-09-18 Merck & Co., Inc. Biomarker for efficacy of appetite suppressant drugs
JP5248854B2 (ja) * 2004-04-01 2013-07-31 リポサイエンス，インコーポレイテッド 臨床ｎｍｒ体外診断解析器の作動方法及び臨床ｎｍｒ体外診断解析器
WO2006098394A1 (ja) * 2005-03-14 2006-09-21 Japan Tobacco Inc. 脂質吸収抑制方法および脂質吸収抑制剤
EP1876448A1 (en) 2005-09-30 2008-01-09 DIGILAB BioVisioN GmbH Method and analytical reagents for identifying therapeutics using biomarkers responsive to thiazolidinediones.

Also Published As

Publication number Publication date
PT2238458E (pt) 2012-01-11
BRPI0821364A2 (pt) 2015-06-16
ES2373625T3 (es) 2012-02-07
DK2238458T3 (da) 2012-01-23
WO2009085927A1 (en) 2009-07-09
CA2710395C (en) 2016-10-18
WO2009085917A1 (en) 2009-07-09
AU2008343177A1 (en) 2009-07-09
ATE530916T1 (de) 2011-11-15
AU2008343177B2 (en) 2013-09-26
PL2238458T3 (pl) 2012-03-30
CA2710248A1 (en) 2009-07-09
JP5242701B2 (ja) 2013-07-24
EP2238458B1 (en) 2011-10-26
CY1112352T1 (el) 2015-12-09
CA2710395A1 (en) 2009-07-09
KR20100088624A (ko) 2010-08-09
BRPI0821051A2 (pt) 2015-06-16
AU2008343187A1 (en) 2009-07-09
HRP20110840T1 (hr) 2011-12-31
KR101240875B1 (ko) 2013-03-08
US20100248375A1 (en) 2010-09-30
US8355877B2 (en) 2013-01-15
BRPI0821051B1 (pt) 2022-02-08
MX2010006890A (es) 2010-09-30
JP2011508218A (ja) 2011-03-10
KR20100084577A (ko) 2010-07-26
EP2235544A1 (en) 2010-10-06
US8084261B2 (en) 2011-12-27
EP2238458A1 (en) 2010-10-13
US20100268474A1 (en) 2010-10-21

Similar Documents

Publication Publication Date Title
EP2203112A4 (en) METHOD, SYSTEM AND COMPUTER SIMULATION ENVIRONMENT FOR VERIFICATION OF MONITORING AND CONTROL STRATEGIES AT DIABETES
WO2012078806A3 (en) Non-gaming on-line achievement awards
EP2587473A4 (en) ACTIVE MATRIX SUBSTRATE, DISPLAY DEVICE AND METHOD FOR TESTING THE ACTIVE MATRIX SUBSTRATE OR DISPLAY DEVICE
EP2219130A4 (en) METHOD AND APPARATUS FOR DETECTING THE MALICIOUS BEHAVIOR OF A COMPUTER PROGRAM
FI20075062A0 (fi) Menetelmä, laite, järjestelmä, tietokoneohjelmatuote ja tietokoneohjelman jakeluväline
EP2317492A4 (en) ACTIVE MATRIX SUBSTRATE, DISPLAY ARRANGEMENT, METHOD FOR STUDYING THE ACTIVE MATRIX SUBSTRATE, AND METHOD FOR STUDYING THE DISPLAY ARRANGEMENT
EP2589937A4 (en) VERIFICATION SYSTEM FOR A LARGE WEIGHING MACHINE AND LOADING AND DISCHARGE MEASURING DEVICE WITH AUTOMATIC LOCALIZATION
WO2008135986A3 (en) System, method and device for comprehensive individualized genetic information or genetic counseling
MY164394A (en) Device and method for determining information related to a medical device
NZ602497A (en) Enterobacter sp. 638 and methods of use thereof
EP2521587A4 (en) RELEASE SYSTEM
AR071165A1 (es) Metodos y aparatos para la recuperacion de inversion en dispositivos medicos
FR2929325B1 (fr) Dispositif et procede d'equilibrage de pression dans une enceinte palier de turboreacteur
PH12015500545A1 (en) Methods for modulating corticosterone levels in psychologically stressed individuals
BRPI0916174A2 (pt) "sistema de exibição, método e produto de programa de computador"
EP2272519A4 (en) METHOD AND PHARMACEUTICAL COMPOSITION FOR ACHIEVING THE PLASMA PROGESTERONE MIRRORS NECESSARY FOR VARIOUS THERAPEUTIC INDICATIONS
BRPI0917616A2 (pt) arranjo para medir a velocidade local de um líquido que contém um material magnético em uma veia dentro de uma região de ação, método para medir a velocidade local de um líquido que contém um material magnético em uma veia dentro de uma região de ação e programa de computador
EP2370931A4 (en) METHOD, APPARATUS AND COMPUTER PROGRAM FOR PROVIDING AN INDEPENDENT ORIENTATION FACIAL DETECTOR
GB2509647A (en) Testing transaction applications
GB0613698D0 (en) Method and apparatus for measuring activity in the peripheral nervous system
EP2513336A4 (en) METHOD FOR CHARACTERIZING THE IMMUNE FUNCTION OF EX VIVO INDUCTIVE HOST OF OFFENSIVE AND DEFENSIVE IMMUNE MARKERS
SI2238458T1 (sl) Metoda za napovedovanje odzivnosti na farmacevtsko zdravljenje debelosti
EP2109824A4 (en) PERIPHERAL COMPUTER DEVICE IMPLEMENTED AS OPTICAL STORAGE DEVICE AND / OR SOFTWARE DEPOSITED DISK AND METHOD FOR IMPLEMENTING SAME
MX337767B (es) Tecnologia de simulacion integrada.
IN2013CN00326A (sl)